CLINICAL_TRIALS
trial_result
· 2016-09-09
Clinical Trial Update: Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment. [Phase 4]
Summary
Phase 4 trial investigating telbivudine for renal function improvement in HBsAg-positive kidney transplant recipients; the study has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Taiwan University Hospital | Conditions: HBsAg-positive Renal Allograft Recipients | Phase 4 | Status: TERMINATED